申请人:Taisho Pharmaceutical Co., Ltd
公开号:US08222417B2
公开(公告)日:2012-07-17
The present invention provides compounds having excellent 11β-HSD1 inhibitory activity.
A compound represented by the following formula (I):
[wherein
X1 represents an oxygen atom, or the formula —(CR11R12)p—, etc.,
Y1 represents a hydrogen atom, a hydroxyl group, etc.,
Z1 represents an oxygen atom or the formula —(NR14)—,
R1 represents a hydrogen atom, a halogen atom, a cyano group, a C1-4 alkyl group, a C1-4 alkyl group substituted with 1 to 3 halogen atoms, a C1-4 alkoxy group, a C1-4 alkoxycarbonyl group, a carboxyl group, a carbamoyl group, or an amino group, and m represents an integer of 1 or 2, and
R2 represents a hydrogen atom or a C1-4 alkyl group, and n represents an integer of 1 or 2].
本发明提供了具有优异11β-HSD1抑制活性的化合物。一种由以下式子(I)表示的化合物:[其中X1表示氧原子,或者式子—(CR11R12)p—等,Y1表示氢原子,羟基等,Z1表示氧原子或式子—(NR14)—,R1表示氢原子,卤素原子,氰基,C1-4烷基,1至3个卤素原子取代的C1-4烷基,C1-4烷氧基,C1-4烷氧羰基,羧基,氨基或氨基甲酰基,m表示1或2的整数,R2表示氢原子或C1-4烷基,n表示1或2的整数]。